Charles Warren Bennington serves as Executive at TransBiotec, Inc., where they oversee executive responsibilities. Since joining the company, Charles Warren Bennington has executed 6 insider transactions totaling $66.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 1, 2021 involved selling 500 shares valued at $1.9K.
Charles Warren Bennington currently holds 455,933 shares of TransBiotec, Inc. (IMLE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Warren Bennington has been a net buyer of IMLE stock. They have purchased $66.5M and sold $10.0K worth of shares.
Charles Warren Bennington's most recent insider trade was on Jul 1, 2021, when they sold 500 shares at $3.80 per share.
Get notified when new Form 4 filings are submitted
| $3.58 |
| Discretionary |
| May 14, 2021 | SOBR | $3.0K | Sale | 1,000 | $3.00 | Discretionary |
| Apr 26, 2021 | SOBR | $3.2K | Sale | 1,000 | $3.20 | Discretionary |
| Apr 7, 2020 | SOBR | $66.0M | Purchase | 6,832 | $9656.03 | Discretionary |
| Aug 28, 2019 | IMLE | $560.0K | Purchase | 14,000,000 | $0.04 | Discretionary |